All news

Tax withholding prompts a proposed 11,087-share sale by Cue Biopharma (CUE) officer Shao-Lee Lin.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Shao-Lee Lin, an officer and director of Cue Biopharma, Inc. (CUE), has proposed to sell 11,087 common shares on October 12, 2026, for an aggregate market value of $305,490.35. This sale is intended to cover tax withholding obligations related to restricted stock unit vesting and is not a discretionary transaction. Lin has previously reported selling shares on August 12 and August 13, 2026.

Read original source

CUE company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.